Once again, the relevant signatures, combined with related immune response and genetic alteration, have demonstrated that the features of EMT regulator CDH2 are significantly associated with m6A regulators ALKBH5, ELAVL1, and WTAP, indicating a synergistic effect on the occurrence and development of ovarian cancer. Here, ELAVL1 is linked to ovarian cancer.